VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,091,000 | -19.5% | 46,929 | -44.9% | 0.47% | -6.7% |
| Q1 2018 | $1,356,000 | +513.6% | 85,200 | +326.0% | 0.51% | +614.1% |
| Q1 2017 | $221,000 | -59.8% | 20,000 | -10.7% | 0.07% | -65.2% |
| Q3 2016 | $550,000 | -31.9% | 22,400 | -44.1% | 0.20% | -24.4% |
| Q2 2016 | $808,000 | +127.6% | 40,100 | +197.0% | 0.27% | +134.8% |
| Q1 2016 | $355,000 | -55.2% | 13,500 | +73.1% | 0.12% | -56.6% |
| Q4 2015 | $793,000 | -61.3% | 7,800 | -32.2% | 0.26% | -61.3% |
| Q3 2015 | $2,051,000 | -54.1% | 11,500 | -42.8% | 0.68% | -48.0% |
| Q2 2015 | $4,465,000 | +2.2% | 20,100 | -8.6% | 1.32% | -8.7% |
| Q1 2015 | $4,370,000 | +59.0% | 22,000 | +14.6% | 1.44% | +34.0% |
| Q4 2014 | $2,748,000 | – | 19,200 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |